Copyright Reports & Markets. All rights reserved.

Global Mental Disorder Treatment Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Mental Disorder Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Medications
    • 1.2.3 Self-help Therapies
  • 1.3 Market by Application
    • 1.3.1 Global Mental Disorder Treatment Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Depression
    • 1.3.3 Bipolar Disorder
    • 1.3.4 Schizophrenia
    • 1.3.5 Dementia
    • 1.3.6 Post-traumatic Stress Disorder
    • 1.3.7 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Mental Disorder Treatment Market Perspective (2016-2027)
  • 2.2 Mental Disorder Treatment Growth Trends by Regions
    • 2.2.1 Mental Disorder Treatment Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Mental Disorder Treatment Historic Market Share by Regions (2016-2021)
    • 2.2.3 Mental Disorder Treatment Forecasted Market Size by Regions (2022-2027)
  • 2.3 Mental Disorder Treatment Industry Dynamic
    • 2.3.1 Mental Disorder Treatment Market Trends
    • 2.3.2 Mental Disorder Treatment Market Drivers
    • 2.3.3 Mental Disorder Treatment Market Challenges
    • 2.3.4 Mental Disorder Treatment Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Mental Disorder Treatment Players by Revenue
    • 3.1.1 Global Top Mental Disorder Treatment Players by Revenue (2016-2021)
    • 3.1.2 Global Mental Disorder Treatment Revenue Market Share by Players (2016-2021)
  • 3.2 Global Mental Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Mental Disorder Treatment Revenue
  • 3.4 Global Mental Disorder Treatment Market Concentration Ratio
    • 3.4.1 Global Mental Disorder Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Mental Disorder Treatment Revenue in 2020
  • 3.5 Mental Disorder Treatment Key Players Head office and Area Served
  • 3.6 Key Players Mental Disorder Treatment Product Solution and Service
  • 3.7 Date of Enter into Mental Disorder Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Mental Disorder Treatment Breakdown Data by Type

  • 4.1 Global Mental Disorder Treatment Historic Market Size by Type (2016-2021)
  • 4.2 Global Mental Disorder Treatment Forecasted Market Size by Type (2022-2027)

5 Mental Disorder Treatment Breakdown Data by Application

  • 5.1 Global Mental Disorder Treatment Historic Market Size by Application (2016-2021)
  • 5.2 Global Mental Disorder Treatment Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Mental Disorder Treatment Market Size (2016-2027)
  • 6.2 North America Mental Disorder Treatment Market Size by Type
    • 6.2.1 North America Mental Disorder Treatment Market Size by Type (2016-2021)
    • 6.2.2 North America Mental Disorder Treatment Market Size by Type (2022-2027)
    • 6.2.3 North America Mental Disorder Treatment Market Size by Type (2016-2027)
  • 6.3 North America Mental Disorder Treatment Market Size by Application
    • 6.3.1 North America Mental Disorder Treatment Market Size by Application (2016-2021)
    • 6.3.2 North America Mental Disorder Treatment Market Size by Application (2022-2027)
    • 6.3.3 North America Mental Disorder Treatment Market Size by Application (2016-2027)
  • 6.4 North America Mental Disorder Treatment Market Size by Country
    • 6.4.1 North America Mental Disorder Treatment Market Size by Country (2016-2021)
    • 6.4.2 North America Mental Disorder Treatment Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Mental Disorder Treatment Market Size (2016-2027)
  • 7.2 Europe Mental Disorder Treatment Market Size by Type
    • 7.2.1 Europe Mental Disorder Treatment Market Size by Type (2016-2021)
    • 7.2.2 Europe Mental Disorder Treatment Market Size by Type (2022-2027)
    • 7.2.3 Europe Mental Disorder Treatment Market Size by Type (2016-2027)
  • 7.3 Europe Mental Disorder Treatment Market Size by Application
    • 7.3.1 Europe Mental Disorder Treatment Market Size by Application (2016-2021)
    • 7.3.2 Europe Mental Disorder Treatment Market Size by Application (2022-2027)
    • 7.3.3 Europe Mental Disorder Treatment Market Size by Application (2016-2027)
  • 7.4 Europe Mental Disorder Treatment Market Size by Country
    • 7.4.1 Europe Mental Disorder Treatment Market Size by Country (2016-2021)
    • 7.4.2 Europe Mental Disorder Treatment Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Mental Disorder Treatment Market Size (2016-2027)
  • 8.2 Asia-Pacific Mental Disorder Treatment Market Size by Type
    • 8.2.1 Asia-Pacific Mental Disorder Treatment Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Mental Disorder Treatment Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Mental Disorder Treatment Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Mental Disorder Treatment Market Size by Application
    • 8.3.1 Asia-Pacific Mental Disorder Treatment Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Mental Disorder Treatment Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Mental Disorder Treatment Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Mental Disorder Treatment Market Size by Region
    • 8.4.1 Asia-Pacific Mental Disorder Treatment Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Mental Disorder Treatment Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Mental Disorder Treatment Market Size (2016-2027)
  • 9.2 Latin America Mental Disorder Treatment Market Size by Type
    • 9.2.1 Latin America Mental Disorder Treatment Market Size by Type (2016-2021)
    • 9.2.2 Latin America Mental Disorder Treatment Market Size by Type (2022-2027)
    • 9.2.3 Latin America Mental Disorder Treatment Market Size by Type (2016-2027)
  • 9.3 Latin America Mental Disorder Treatment Market Size by Application
    • 9.3.1 Latin America Mental Disorder Treatment Market Size by Application (2016-2021)
    • 9.3.2 Latin America Mental Disorder Treatment Market Size by Application (2022-2027)
    • 9.3.3 Latin America Mental Disorder Treatment Market Size by Application (2016-2027)
  • 9.4 Latin America Mental Disorder Treatment Market Size by Country
    • 9.4.1 Latin America Mental Disorder Treatment Market Size by Country (2016-2021)
    • 9.4.2 Latin America Mental Disorder Treatment Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Mental Disorder Treatment Market Size (2016-2027)
  • 10.2 Middle East & Africa Mental Disorder Treatment Market Size by Type
    • 10.2.1 Middle East & Africa Mental Disorder Treatment Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Mental Disorder Treatment Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Mental Disorder Treatment Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Mental Disorder Treatment Market Size by Application
    • 10.3.1 Middle East & Africa Mental Disorder Treatment Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Mental Disorder Treatment Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Mental Disorder Treatment Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Mental Disorder Treatment Market Size by Country
    • 10.4.1 Middle East & Africa Mental Disorder Treatment Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Mental Disorder Treatment Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Allergan Plc
    • 11.1.1 Allergan Plc Company Details
    • 11.1.2 Allergan Plc Business Overview
    • 11.1.3 Allergan Plc Mental Disorder Treatment Introduction
    • 11.1.4 Allergan Plc Revenue in Mental Disorder Treatment Business (2016-2021)
    • 11.1.5 Allergan Plc Recent Development
  • 11.2 Eli Lilly and Company
    • 11.2.1 Eli Lilly and Company Company Details
    • 11.2.2 Eli Lilly and Company Business Overview
    • 11.2.3 Eli Lilly and Company Mental Disorder Treatment Introduction
    • 11.2.4 Eli Lilly and Company Revenue in Mental Disorder Treatment Business (2016-2021)
    • 11.2.5 Eli Lilly and Company Recent Development
  • 11.3 VistaGen Therapeutics
    • 11.3.1 VistaGen Therapeutics Company Details
    • 11.3.2 VistaGen Therapeutics Business Overview
    • 11.3.3 VistaGen Therapeutics Mental Disorder Treatment Introduction
    • 11.3.4 VistaGen Therapeutics Revenue in Mental Disorder Treatment Business (2016-2021)
    • 11.3.5 VistaGen Therapeutics Recent Development
  • 11.4 Sanofi S.A
    • 11.4.1 Sanofi S.A Company Details
    • 11.4.2 Sanofi S.A Business Overview
    • 11.4.3 Sanofi S.A Mental Disorder Treatment Introduction
    • 11.4.4 Sanofi S.A Revenue in Mental Disorder Treatment Business (2016-2021)
    • 11.4.5 Sanofi S.A Recent Development
  • 11.5 Novartis International AG
    • 11.5.1 Novartis International AG Company Details
    • 11.5.2 Novartis International AG Business Overview
    • 11.5.3 Novartis International AG Mental Disorder Treatment Introduction
    • 11.5.4 Novartis International AG Revenue in Mental Disorder Treatment Business (2016-2021)
    • 11.5.5 Novartis International AG Recent Development
  • 11.6 Mylan N.V
    • 11.6.1 Mylan N.V Company Details
    • 11.6.2 Mylan N.V Business Overview
    • 11.6.3 Mylan N.V Mental Disorder Treatment Introduction
    • 11.6.4 Mylan N.V Revenue in Mental Disorder Treatment Business (2016-2021)
    • 11.6.5 Mylan N.V Recent Development
  • 11.7 Amneal Pharmaceuticals LLC
    • 11.7.1 Amneal Pharmaceuticals LLC Company Details
    • 11.7.2 Amneal Pharmaceuticals LLC Business Overview
    • 11.7.3 Amneal Pharmaceuticals LLC Mental Disorder Treatment Introduction
    • 11.7.4 Amneal Pharmaceuticals LLC Revenue in Mental Disorder Treatment Business (2016-2021)
    • 11.7.5 Amneal Pharmaceuticals LLC Recent Development
  • 11.8 Cipla Ltd
    • 11.8.1 Cipla Ltd Company Details
    • 11.8.2 Cipla Ltd Business Overview
    • 11.8.3 Cipla Ltd Mental Disorder Treatment Introduction
    • 11.8.4 Cipla Ltd Revenue in Mental Disorder Treatment Business (2016-2021)
    • 11.8.5 Cipla Ltd Recent Development
  • 11.9 Sun Pharmaceutical Industries Ltd
    • 11.9.1 Sun Pharmaceutical Industries Ltd Company Details
    • 11.9.2 Sun Pharmaceutical Industries Ltd Business Overview
    • 11.9.3 Sun Pharmaceutical Industries Ltd Mental Disorder Treatment Introduction
    • 11.9.4 Sun Pharmaceutical Industries Ltd Revenue in Mental Disorder Treatment Business (2016-2021)
    • 11.9.5 Sun Pharmaceutical Industries Ltd Recent Development
  • 11.10 Glenmark Pharmaceuticals Limited
    • 11.10.1 Glenmark Pharmaceuticals Limited Company Details
    • 11.10.2 Glenmark Pharmaceuticals Limited Business Overview
    • 11.10.3 Glenmark Pharmaceuticals Limited Mental Disorder Treatment Introduction
    • 11.10.4 Glenmark Pharmaceuticals Limited Revenue in Mental Disorder Treatment Business (2016-2021)
    • 11.10.5 Glenmark Pharmaceuticals Limited Recent Development
  • 11.11 Lupin Limited
    • 11.11.1 Lupin Limited Company Details
    • 11.11.2 Lupin Limited Business Overview
    • 11.11.3 Lupin Limited Mental Disorder Treatment Introduction
    • 11.11.4 Lupin Limited Revenue in Mental Disorder Treatment Business (2016-2021)
    • 11.11.5 Lupin Limited Recent Development
  • 11.12 Janssen Pharmaceutica
    • 11.12.1 Janssen Pharmaceutica Company Details
    • 11.12.2 Janssen Pharmaceutica Business Overview
    • 11.12.3 Janssen Pharmaceutica Mental Disorder Treatment Introduction
    • 11.12.4 Janssen Pharmaceutica Revenue in Mental Disorder Treatment Business (2016-2021)
    • 11.12.5 Janssen Pharmaceutica Recent Development
  • 11.13 Bristol Myers Squibb
    • 11.13.1 Bristol Myers Squibb Company Details
    • 11.13.2 Bristol Myers Squibb Business Overview
    • 11.13.3 Bristol Myers Squibb Mental Disorder Treatment Introduction
    • 11.13.4 Bristol Myers Squibb Revenue in Mental Disorder Treatment Business (2016-2021)
    • 11.13.5 Bristol Myers Squibb Recent Development
  • 11.14 Sumitomo Dainippon Pharma Co., Ltd
    • 11.14.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
    • 11.14.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
    • 11.14.3 Sumitomo Dainippon Pharma Co., Ltd Mental Disorder Treatment Introduction
    • 11.14.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Mental Disorder Treatment Business (2016-2021)
    • 11.14.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Mental Disorder Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mental Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Medications
    Self-help Therapies

    Segment by Application
    Depression
    Bipolar Disorder
    Schizophrenia
    Dementia
    Post-traumatic Stress Disorder
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Allergan Plc
    Eli Lilly and Company
    VistaGen Therapeutics
    Sanofi S.A
    Novartis International AG
    Mylan N.V
    Amneal Pharmaceuticals LLC
    Cipla Ltd
    Sun Pharmaceutical Industries Ltd
    Sanofi S.A
    Novartis International AG
    Janssen Pharmaceutica
    Bristol Myers Squibb

    Buy now